Stay updated on Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma
Sign up to get notified when there's something new on the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page.

Latest updates to the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe study record history shows a new revision v3.6.3 replacing v3.6.2, indicating a small administrative update to the page's versioning.SummaryDifference0.1%

- Check20 days agoChange DetectedA new revision entry (v3.6.2) was added to the study record history, and the previous revision (v3.6.0) was removed from the visible history. This reflects an administrative update to the version history rather than changes to study content.SummaryDifference0.1%

- Check34 days agoChange DetectedA new site revision entry (v3.6.0) was added to the record history, replacing the previous revision (v3.5.5), indicating a software update to the history tracking.SummaryDifference0.6%

- Check41 days agoChange DetectedA new revision entry labeled v3.5.5 has been added to the study’s record history, following the previous v3.5.4, indicating the record has been updated to a newer version.SummaryDifference0.1%

- Check55 days agoChange DetectedA new Revision: v3.5.4 entry has been added to the record history. The previous Revision: v3.5.3 entry has been removed.SummaryDifference0.1%

- Check77 days agoChange DetectedA new revision entry, v3.5.3, was added to the Record History, replacing the previous v3.5.2 as the latest version.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page.